Clinical Trial Update: The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial results evaluating fondaparinux for preventing venous thromboembolism in high-risk trauma patients; the study is completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: Mary Knudson, M.D. | Conditions: Venous Thromboembolism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-12-24